{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:02:43Z","timestamp":1788397363933,"version":"build-2803163510"},"reference-count":38,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T00:00:00Z","timestamp":1525651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Serial monitoring of Epstein\u2010Barr virus (<jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content>) reveals that certain pediatric liver transplant (<jats:styled-content style=\"fixed-case\">LT<\/jats:styled-content>) recipients exhibit high <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content> loads for long periods. We investigated the incidence and risk factors of chronic high <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">CHEBV<\/jats:styled-content>) loads (continuous <jats:styled-content style=\"fixed-case\">EBV DNA<\/jats:styled-content> &gt;10\u00a0000\u00a0<jats:styled-content style=\"fixed-case\">IU<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content> of whole blood for \u22656\u00a0months) and long\u2010term outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This single center, retrospective observational study investigated pediatric <jats:styled-content style=\"fixed-case\">LT<\/jats:styled-content> recipients who survived \u22656\u00a0months. We quantitated <jats:styled-content style=\"fixed-case\">EBV DNA<\/jats:styled-content> weekly during hospitalization and subsequently every 4 or 6\u00a0weeks at the outpatient clinic. Tacrolimus was maintained at a low trough level (&lt;3\u00a0ng\/mL, <jats:styled-content style=\"fixed-case\">EBV DNA<\/jats:styled-content> load &gt;5000\u00a0<jats:styled-content style=\"fixed-case\">IU<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirty\u2010one of 77 <jats:styled-content style=\"fixed-case\">LT<\/jats:styled-content> recipients developed <jats:styled-content style=\"fixed-case\">CHEBV<\/jats:styled-content>. Univariate analysis revealed that age &lt;2\u00a0years and body weight &lt;10\u00a0kg upon <jats:styled-content style=\"fixed-case\">LT<\/jats:styled-content>, operation time &lt;700\u00a0minutes, warm ischemia time (<jats:styled-content style=\"fixed-case\">WIT<\/jats:styled-content>) &gt;35\u00a0minutes, graft\u2010to\u2010recipient weight ratio (<jats:styled-content style=\"fixed-case\">GRWR<\/jats:styled-content>) &gt;2.7%, and preoperative <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content> seronegativity were significantly associated with the development of <jats:styled-content style=\"fixed-case\">CHEBV<\/jats:styled-content> loads. Multivariate analysis identified significant associations of <jats:styled-content style=\"fixed-case\">CHEBV<\/jats:styled-content> with <jats:styled-content style=\"fixed-case\">WIT<\/jats:styled-content> &gt;35\u00a0minutes, <jats:styled-content style=\"fixed-case\">GRWR<\/jats:styled-content> &gt;2.7%, and preoperative seronegative. None of the recipients developed post\u2010transplantation lymphoproliferative disorder. Survival rates of patients with and without <jats:styled-content style=\"fixed-case\">CHEBV<\/jats:styled-content> loads were not significantly different.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A significant number of pediatric <jats:styled-content style=\"fixed-case\">LT<\/jats:styled-content> recipients developed <jats:styled-content style=\"fixed-case\">CHEBV<\/jats:styled-content> loads. Long <jats:styled-content style=\"fixed-case\">WIT<\/jats:styled-content>, high <jats:styled-content style=\"fixed-case\">GRWR<\/jats:styled-content>, and preoperative <jats:styled-content style=\"fixed-case\">EBV<\/jats:styled-content> seronegativity were significantly associated with the development of <jats:styled-content style=\"fixed-case\">CHEBV<\/jats:styled-content> loads. Although the long\u2010term outcomes of patients with or without <jats:styled-content style=\"fixed-case\">CHEBV<\/jats:styled-content> loads were not significantly different, further studies of more subjects are warranted.<\/jats:p><\/jats:sec>","DOI":"10.1111\/tid.12911","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T16:12:32Z","timestamp":1524240752000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Risk factors and long\u2010term outcomes of pediatric liver transplant recipients with chronic high Epstein\u2010Barr virus loads"],"prefix":"10.1111","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8299-3613","authenticated-orcid":false,"given":"Hideya","family":"Kamei","sequence":"first","affiliation":[{"name":"Departments of Transplantation Surgery Nagoya University Hospital  Showa Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Nagoya University Graduate School of Medicine  Showa Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kawada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Nagoya University Graduate School of Medicine  Showa Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ogiso","sequence":"additional","affiliation":[{"name":"Departments of Transplantation Surgery Nagoya University Hospital  Showa Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Onishi","sequence":"additional","affiliation":[{"name":"Departments of Transplantation Surgery Nagoya University Hospital  Showa Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Komagome","sequence":"additional","affiliation":[{"name":"Departments of Transplantation Surgery Nagoya University Hospital  Showa Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Kurata","sequence":"additional","affiliation":[{"name":"Departments of Transplantation Surgery Nagoya University Hospital  Showa Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ogura","sequence":"additional","affiliation":[{"name":"Departments of Transplantation Surgery Nagoya University Hospital  Showa Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,5,7]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.2001.00021.x"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199502270-00015"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000057244.03192.BD"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199608150-00012"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199711270-00011"},{"key":"e_1_2_9_7_1","first-page":"94","article-title":"The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients","volume":"70","author":"Younes BS","year":"2000","journal-title":"Transplantation"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.1999.00066.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01002.x"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200109270-00006"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.582"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.02080.x"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.2003.02051.x"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20958"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1086\/653737"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2008.00926.x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200207270-00009"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.2.280"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01515-06"},{"key":"e_1_2_9_20_1","unstructured":"FryerJF HeathAB WilkinsonDE MinorPD the collaborative study group.Collaborative study to evaluate the proposed 1st WHO international standard for Epstein\u2010Barr virus (EBV) for nucleic acid amplification technology (NAT)\u2010based assays.2011.http:\/\/apps.who.int\/iris\/handle\/10665\/70781. Accessed February 26 2018."},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2002.tb00102.x"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.2.613-619.2000"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1165"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2010.00243.x"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.895677"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198804000-00011"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.04.035"},{"issue":"1","key":"e_1_2_9_28_1","first-page":"75","article-title":"Contrast patterns of cytomegalovirus and Epstein\u2010Barr virus infection in pediatric living\u2010donor liver transplant recipients","volume":"13","author":"Nafady\u2010Hego H","year":"2015","journal-title":"Exp Clin Transplant"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.23659"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000219817.18049.36"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2010.09.134"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.24078"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00912.x"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2011.01535.x"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80262-0"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2005.06.014"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.6.1612-1615.1997"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.9.2715.2715"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis823"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftid.12911","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.12911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T15:52:48Z","timestamp":1694965968000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.12911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1111\/tid.12911"],"URL":"https:\/\/doi.org\/10.1111\/tid.12911","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,7]]},"assertion":[{"value":"2017-09-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e12911"}}